These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7160585

  • 1. Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide.
    Abe S, Tsubouchi J, Takahashi K, Yamazaki M, Mizuno D.
    Gan; 1982 Dec; 73(6):961-7. PubMed ID: 7160585
    [Abstract] [Full Text] [Related]

  • 2. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
    Moriya N, Miwa H, Taketsuka S, Orita K.
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy of murine tumors with lentinan, bacterial lipopolysaccharide and a Streptococcus preparation, OK432.
    Abe S, Takahashi K, Tsubouchi J, Yamazaki M, Mizuno D.
    Gan; 1983 Apr; 74(2):273-8. PubMed ID: 6862148
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effect of bacterial lipopolysaccharide (LPS) alone and in combination with lentinan on MH-134 tumors in C3H/He mice.
    Moriya N, Miwa H, Orita K.
    Acta Med Okayama; 1984 Feb; 38(1):49-55. PubMed ID: 6702486
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effect of polysaccharide lentinan on MH-134 ascites hepatoma in C3H/He mice.
    Moriyama M.
    Acta Med Okayama; 1982 Feb; 36(1):49-60. PubMed ID: 7064733
    [Abstract] [Full Text] [Related]

  • 6. Complete regression of Lewis lung carcinoma by cyclophosphamide in combination with immunomodulators.
    Abe S, Takahashi K, Yamazaki M, Mizuno D.
    Jpn J Cancer Res; 1985 Jul; 76(7):626-30. PubMed ID: 3928559
    [Abstract] [Full Text] [Related]

  • 7. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors.
    Abe S, Yoshioka O, Masuko Y, Tsubouchi J, Kohno M, Nakajima H, Yamazaki M, Mizono D.
    Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination therapy of murine tumors with a degraded D-manno-D-glucan (DMG) from Microellobosporia grisea, and cyclophosphamide.
    Nakajima H, Hashimoto S, Kita Y, Takashi T, Tsukada W, Kohno M, Ogawa H, Abe S, Mizuno D.
    Jpn J Exp Med; 1983 Dec; 53(6):263-9. PubMed ID: 6240552
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
    Gatanaga T, Takahashi K, Yamazaki M, Mizuno D, Abe S.
    Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
    Inagawa H, Nishizawa T, Honda T, Nakamoto T, Takagi K, Soma G.
    Anticancer Res; 1998 Jul; 18(5D):3957-64. PubMed ID: 9854510
    [Abstract] [Full Text] [Related]

  • 13. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL, Kariev NI, Mainardi JV, Betancourt M, Lage A, Barroso MC, Alfonso L.
    Neoplasma; 1982 Jul; 29(1):65-71. PubMed ID: 7070556
    [Abstract] [Full Text] [Related]

  • 14. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K, Tanaka T, Takeuchi M.
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different local therapeutic effects of various polysaccharides on MH134 hepatoma in mice and its relation to inflammation induced by the polysaccharides.
    Abe S, Takahashi K, Tsubouchi J, Aida K, Yamazaki M, Mizuno D.
    Gan; 1984 May; 75(5):459-65. PubMed ID: 6745566
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction.
    Masuko Y, Nakajima H, Tsubouchi J, Yamazaki M, Mizuno D, Abe S.
    Gan; 1982 Oct; 73(5):790-7. PubMed ID: 7166231
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
    Inagawa H, Nishizawa T, Noguchi K, Minamimura M, Takagi K, Goto S, Soma G, Mizuno D.
    Anticancer Res; 1997 Oct; 17(3C):2153-8. PubMed ID: 9216680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.